MSRP : US$120
Weight : 12.7 oz / 361 gm
Predecessor : Gel 3000
Product Cycle : RY.2009.→DY.2010.Jun.
Features : Gel®, Space Trusstic System™, I.G.S.®, Dynamic Cradle, AHAR+, PHF™, Solyte™, Biomorphic Fit™
: | A daily high milage trainer with rich features for "Mild over-pronation to Late-stage severe over-pronation". |
AHAR+ Heel : A thinner and lighter version of Asics High Abrasion Resistance rubber. It is placed on the impact area of the outsole to reduce excessive wear.
Biomorphic Fit : Provides enhanced upper fit and comfort while decreasing potential for irritation.
Dynamic Cradle™ : Supports and guides the foot.
Gel® : Provides maximum rearfoot and forefoot shock attenuation.
I.G.S.® : Impact Guidance System : Asics® design philosophy that uses linked componentry to encourage optimal gait while allowing for natural foot movement from heel strike to toe-off.
PHF™ : Personal Heel Fit System : Moulds and customises itself to the individual heel shape of the wearer.
Solyte™ : The advantage to injected Solyte® is a much more consistent density, ensuring that the desired softness is more ‘dialed in’ than standard compression molded midsole material. Injected Solyte® is also lighter than standard Solyte® contributing to the overall drop in weight.
Space Trusstic System™ : The system works with the complex functions of the foot to facilitate Windlass Mechanics. Space Trusstic is new I.G.S. componentry and an evolution, if not revolution of our benchmark trusstic technology. The Space Trusstic system is not integrated within the EVA. Rather it is suspended below the midsole EVA forming a distinct pocket or space into which the EVA of the mid foot section of the shoe can distort. The result is that torsion stability of the shoe is maintained but pressure on the plantar facia is released enabling tension with the transition from foot flat to propulsion. This is designed to facilitate the all-important Windlass Mechanism. Space Trusstic is a natural extension of I.G.S. and an enhancement of Windlass Mechanics.
No comments:
Post a Comment